Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Diabetes, Low HDL, High Homocysteine Levels Predict Poorer Stroke Recovery
Link ID 1260
Title Diabetes, Low HDL, High Homocysteine Levels Predict Poorer Stroke Recovery
Url http://www.medscape.com/viewarticle/566641?src=rss
Description Vascular risk factors linked with metabolic stress, including diabetes, low levels of high-density lipoprotein cholesterol, and elevated homocysteine predict slower stroke recovery. Medscape Medical News
Category Articles > Cardiology
Keywords
Date Dec 3, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Reduced Hospitalizations for ACS Following Smoking Ban in Scotland
  A ban that prohibits smoking in all enclosed places throughout Scotland has led to a decrease in the number of hospital admissions for acute coronary syndrome, and the benefit of the smoking ban has extended to smokers, former smokers, and those who never smoked, a new study has shown. Heartwire
Category:   Articles > Cardiology


2. Prevention of Thromboembolic Complications Following Acute Ischemic Stroke
  Patients who have had an ischemic stroke are at high risk for VTE. These cases will highlight key factors in the prevention, diagnosis, and management of VTE in post-stroke patients. Medscape Neurology & Neurosurgery
Category:   Articles > Cardiology


3. Largest US Registry Study Supports Two-Year Safety, Reduced Revascularizations, for DES
  At two years, DES were associated with comparable MI rates but statistically significant reductions in mortality and revascularizations. Investigators say they will continue to track the 17 000+ patients for at least five years, but for now the findings are "reassuring." Heartwire
Category:   Articles > Cardiology


4. Echo Contrast Agents "Safe"; FDA Should Reconsider Warnings
  A new analysis has shown that the benefits of using ultrasound contrast agents outweigh the risks. Most important, withholding the use of such agents in patients who need them can be detrimental, says the lead investigator. Reporting her findings last week, she called on the FDA to reconsider the warnings it has placed on these products. Heartwire
Category:   Articles > Cardiology


5. ONTARGET MRI Study: No Benefit of Combination Therapy on Left Ventricular Mass
  A new ONTARGET imaging study has shown no difference between ramipril, telmisartan, or the combination in the reduction of left ventricular mass. The MRI study, say investigators, closely parallels the main findings from ONTARGET, showing no clear advantage to combination therapy. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS